Highly efficient transduction and expression of cytokine genes in human tumor cells by means of autonomous parvovirus vectors; generation of antitumor responses in recipient mice

Human Gene Therapy

Volumn 11, Issue 4, 2000, Pages 597-609

  Haag, Andreas ^a   Menten, Patricia ^b   Van Damme, Jo ^b   Dinsart, Christiane ^a   Rommelaere, Jean ^a   Cornelis, Jan J ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; MONOCYTE CHEMOTACTIC PROTEIN 1; VIRUS VECTOR;

ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER TRANSPLANTATION; CELL INFILTRATION; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; GENE EXPRESSION; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; NUDE MOUSE; PARVOVIRUS; TUMOR CELL; VIRUS RECOMBINANT;

ANIMALS; BASE SEQUENCE; CELL LINE; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; DNA PRIMERS; FEMALE; GENE EXPRESSION REGULATION; GENETIC VECTORS; HUMANS; MICE; MICE, NUDE; NEOPLASMS, EXPERIMENTAL; PARVOVIRUS; RECOMBINATION, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSDUCTION, GENETIC; TRANSGENES; VIRAL NONSTRUCTURAL PROTEINS;

ANIMALIA; H1 VIRUS; MIRIDAE; MUS MUSCULUS; PARVOVIRUS;

EID: 0034096105     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430340050015789     Document Type: Article

References (43)

1. Addison, C.L., Braciak, T., Ralston, R., Muller, W., Gauldie, J., and Graham, F.L. (1995). Intratumoral injection of an adenovirus expressing interleukin 2 induces regression and immunity in amurine breastcancer model. Proc. Natl. Acad. Sci. U.S.A. 92, 855-8526.
2. Alosco, T., Ann Croy, B., Gansbacher, B., Wang, H.-Q., Rao, U., and Bankert, R. (1993). Antitumor response independent of functional B or T lymphocytes induced by the local and sustained release of interleukin-2 by the tumor cells. Cancer Immunol. Immunother. 36, 364-372.
3. + lymphokine-activated killer subset. J. Immunol. 150, 17-30.
4. Berns, K.I. (1996). Parvoviridae: The viruses and their replication. In Virology. B.N. Fields, D.M. Knipe, and P.M. Howley, eds. (Lippincott-Raven, Philadelphia, PA) pp. 2173-2197.
5. Bottazzi, B., Walter, S., Govoni, D., Colotta, F., and Mantovani, A. (1992). Monocyte chemotactic cytokine gene transfer modulates macrophage infiltration, growth and susceptibility to IL2 therapy of a murine melanoma. J. Immunol. 1448, 1280-1285.
6. Brockhaus, K., Plaza, S., Pintel, D.J., Rommelaere, J., and Salome, N. (1997). Nonstructural proteins NS2 of minute virus of mice associate in vivo with 14-3-3 protein family members. J. Virol. 70, 7527-7534.
7. Caillet-Fauquet, P., Perros, M., Brandenburger, A., Spegelaere, P., and Rommelaere, J. (1990). Programmed killing of human cells by means of an inducible clone of parvoviral genes encoding non-structural proteins. EMBO J. 9, 2989-2995.
8. Cornelis, J.J., Chen, Y.Q., Spruyt, N., Duponchel, N., Cotmore, S.F., Tattersall, P., and Rommelaere, J. (1990). Susceptibility of human cells to killing by the paroviruses H-1 and minute virus of mice correlates with viral transcription. J. Virol. 64, 2537-2544.
9. Corrias, M.V., Basso, S., Meazza, R., Musiani, P., Santi, L., Bocca, P., Occhino, M., Ferrini, S., and Pistoia, V. (1998). Characterization and tumorigenicity of human neuroblastoma cells transfected with the IL-2 gene. Cancer Gene Ther. 5, 38-44.
10. Deleu, L., Pujol, A., Faisst, S., and Rommelaere, J. (1999). Activation of promoter P4 of the autonomous parvovirus minute virus of mice at early S phase is required for productive infection. J. Virol. 73, 3877-3885.
11. Dupont, F., Tenenbaum, L., Guo, P., Spegelaere, P., Zeicher, M., and Rommelaere, J. (1994). Use of an autonomous parvovirus vector for selective transfer of a foreign gene into transformed human cells of different tissue origins and its expression therein. J. Virol. 68, 1397-1407.
12. Dupressoir, T., Vanacker, J.-M., Cornelis, J.J., Duponchel, N., and Rommelaere, J. (1989). Inhibition by parvovirus H-1 of the formation of tumors in nude mice and colonies in vitro by transformed human mammary epithelial cells. Cancer Res. 49, 3203-3208.
13. Egilmez, N.K., Cuenca, R., Yokota, S.J., Sorgi, F., and Bankert, R.B. (1996). In vivo cytokine gene therapy of human tumor xenografts in SCID mice by liposome-mediated DNA delivery. Gene Ther. 3, 607-614.
14. Faisst, S., Guittard, D., Benner, A., Cesbron, J.Y., Schlehofer, J.R., Rommelaere, J., and Dupressoir, T. (1998). Dose-dependent regression of HeLa cell-derived tumors in SCID mice after parvovirus H-1 infection. Int. J. Cancer 75, 584-589.
15. Fearon, E.R., Pardoll, D.M., Itaya, T., Golumbek, P., Levitsky, H.I., SIMONS, J.W., Karasuyama, H., Vogelstein, B., and Frost, P. (1990). Interleukin 2 production by tumor cells bypasses T helper function in the generation of an antitumor response. Cell 60, 397-404.
16. Gansbacher, B., Zier, K., Daniels, B., Cronin, K., Bannerji, R., and Gilboa, E. (1990). Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity. J. Exp. Med. 172, 1271-1224.
17. Grimm, E.A., Mazumder, A., Zhang, H.Z., and Rosenberg, S.A. (1982). The lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes. J. Exp. Med. 155, 1823-1841.
18. Guetta, E., Graziani, Y., and Tal, J. (1986). Suppression of Ehrlich ascites tumors in mice by minute virus of mice. J. Natl. Cancer Inst. 76, 1177-1180.
19. Hirose, K., Hakozaki, M., Nyunoya, Y., Kobayashi, Y., Matsushita, K., Takenouchi, T., Mikata, A., Mukaida, M., and Matsushima, K. (1995). Chemokine gene transfection into tumour cells reduced tumorigenicity in nude mice in association with neutrophilic infiltration. Br. J. Cancer 72, 708-714.
20. Huang, H., Chen, S.H., Kosai, K., Finegold, M.J., and Woo, S.L.C. (1996). Gene therapy for hepatocellular carcinoma: Long-term remission of primary and metastatic tumors in mice by interleukin-2 gene therapy in vivo. Gene Ther. 3, 980-987.
21. Huang, S., Singh, R.K., Xie, K., Gutman, M., Berry, K.K., Bucana, C.D., Fidler, I.J., and Bar-Eli, M. (1994). Expression of the JE/MCP-1 gene suppresses metastatic potential in murine colon carcinoma cells. Cancer Immunol. Immunother. 39, 231-238.
22. Huang, S., Xie, K., Singh, R.K., Gutman, M., and Bar-Eli, M. (1995). Suppression of tumor growth and metastasis of murine renal adenocarcinoma by syngeneic fibroblasts genetically engineered to secrete the JE/MCP-1 cytokine. J. Interferon Cytokine Res. 15, 655-665.
23. Karp, S.E., Farber, A., Salo, J.C., Hwu, P., Jaffe, G., Asher, A.L., Shiloni, E., Restifo, N.P., Mulé, J.J., and Rosenberg, S.A. (1993). Cytokine secretion by genetically modified non-immunogenic murine fibrosarcoma. J. Immunol. 150, 896-908.
24. Kestler, J., Neeb, B., Struyf, S., Van Damme, J., Cotmore, S.F., D'Abramo, A., Tattrsall, P., Rommelaere, J., Dinsart, C., and Cornelis, J.J. (1999). Cis-requirements for the efficient production of recombinant DNA vectors based on autonomous parvoviruses. Hum. Gene Ther. 10, 1619-1632.
25. Kleine, K., Koenig, G., Kreutzer, J., Komitowski, D., Zur Hausen, H., and Rösl, F. (1995). The effect of the JE (MCP-1) gene, which encodes monocyte chemoattractant protein-1, on the growth of HeLa cells and derived somatic-cell hybrids in nude mice. Mol. Carcinogenesis 14, 170-189.
26. Lorson, C., Pearson, J., Burger, L., and Pintel, D.J. (1998). An SP1-binding site and TATA element are sufficient to support full transactivation by proximally bound NS1 protein of minute virus of mice. Virology 240, 326-333.
27. McKisic, M.D., Paturzo, F.X., and Smith, A.L. (1996). Mouse parvovirus infection potentiates rejection of tumor allografts and modulates T cell effector functions. Transplantation 61, 292-299.
28. Moffat, S., Yaegashi, N., Tada, K., Tanaka, N., and Sigamura, K. (1998). Human parvovirus B19 nonstructural (NSI) protein induces apoptosis in erythroid lineage cells. J. Virol. 72, 3018-3028.
29. Moller, G. (1980). T-cell stimulating factors. Immunol. Rev. 51, 338-357.
30. Mulé, J.J., Yang, J.C., Lafreniere, R.L. Shu, S., and Rosenberg, S.A. (1987). Identification of cellular mechanisms operational in vivo during the regression of established pulmonary metastases by the systemic administration of high-dose recombinant interleukin 2. J. Immunol. 139, 285-294.
31. Opdenakker, G., and Van Damme, J. (1997). Novel monocyte chemoattractants in cancer. In Chemokines and Cancer. B.J. Rollins, ed. (Humana Press, Totowa, NJ) pp. 51-69.
32. Parmiani, G., Colombo, M.P., Melani, C., and Arienti, F. (1997). Cytokine gene transduction in the immunotherapy of cancer. Adv. Pharmacol. 40, 259-307.
33. Proost, P., Struyf, S., Couvreur, M., Lenaerts, J.-P., Conings, R., Menten, P., Verhaert, P., Wuyts, A., and Van Damme, J. (1998). Post-translational modifications affect the activity of the human monocyte chemotactic proteins MCP-1 and MCP-2; Identification of MCP-2(6-76) as a natural chemokine inhibitor. J. Immunol. 160, 4034-4041.
34. Puisieux, I., Odin, L., Poujol, D., Moingeon, P., Tartaglia, J., Cox, W., and Favrot, M. (1998). Canarypox virus-mediated interleukin 12 gene transfer into murine mammary adenocarcinoma induces tumor suppression and long-term antitumoral immunity. Hum. Gene Ther. 9, 2481-2492.
35. Rayet, B., Lopez-Guerrero, J.A., Rommelaere, J., and Dinsart, C. (1998). Induction of programmed cell death by parvovirus H-1 in U937 cells; branching with the TNFα signaling pathway. J. Virol. 72, 8893-8903.
36. Rollins, B.J., and Sunday, M.E. (1991). Suppression of tumor formation in vivo by expression of the JE gene in malignant cells. Mol. Cell. Biol. 11, 3125-3131.
37. Rollins, B.J. (1996). Monocyte chemoattractant protein 1: A potential regulator of monocyte recruitment in inflammatory disease. Mol. Med. Today 2, 198-204.
38. Rommelaere, J., and Cornelis, J.J. (1991). Antineoplasic activity of parvoviruses. J. Virol. Methods 33, 233-251.
39. Rösl, R., Lengert, M., Albrecht, J., Kleine, K., Zawatzky, R., Schraven, B., and Zur Hausen, H. (1994). Differential regulation of the JE gene encoding the monocyte chemoattractant protein (MCP-1) in cervical carcinoma cells and derived hybrids. J. Virol. 68, 2142-2150.
40. Russell, S.J., Brandenburger, A., Flemming, C.L., Collins, M.K.L., and Rommelaere, J. (1992). Transformation-dependent expression of interleukin genes delivered by a recombinant parvovirus. J. Virol. 66, 2821-2828.
41. Shresta, S., Pham, C., Thomas, D., Graubert, T., and Ley, T. (1998). How do cytotoxic lymphocytes kill their targets. Curr. Topics Immunol. 10, 581-587.
42. Struyf, S., Van Coillie, E., Paemen, L., Put, W., Lenaerts, J.-P., Proost, P., Opdenakker, G., and Van Damme, J. (1998). Synergistic induction of MCP-1 and -2 by IL-1B and interferons in fibroblasts and epithelial cells. J. Leukocyte Biol. 63, 364-372.
43. Vanacker, J.-M., and Rommelaere, J. (1995). Non-structural proteins of autonomous parvoviruses: From cellular effects to molecular mechanisms. Semin. Virol. 6, 291-297.